RESUMEN
OBJECTIVE: The susceptibility of two cell lines, WEHI-3B myelomonocytic leukaemia and its variant Ciprofloxacin-resistant WEHI-3B/CPX to undergo apoptosis induced by Ciprofloxacin was studied and compared. MATERIALS AND METHODS: Apoptosis was checked by measuring the DNA fragmentation and determining the ratio of apoptotic/necrotic cells. The relationship between the induction of apoptosis and G(1), S or G(2) block in the cell cycle has also been investigated and cytogenetical evaluation of chromosomal aberrations in both cell lines has been carried out. The regulation of expression of Bax and Bcl-2 was also checked by western blotting after Ciprofloxacin treatment. RESULTS: We observed that the resistance of the subline was caused by a small percentage of cells that underwent apoptosis during continuous exposure to Ciprofloxacin in comparison with the parental cell line, whereas the percentage of necrotic cells remained unchanged. The WEHI-3B cells showed a G(2) block and a higher degree of cytogenetic damage after drug exposure. The two cell lines expressed the same level of Bax and Bcl-2 following stimulation by Ciprofloxacin. Only in the resistant subclone, the ratio Bcl-2/Bax reversed in the anti-apoptotic gene expression. CONCLUSION: The resistance to ciprofloxacin observed is not related to mitochondrial function and although Bcl-2/Bax ratio behaviour does not fully explain the resistance of the WEHI3B/CPX subclone it is consistent with phenotypic character of resistance to CPX. The toxic effect on sensitive cells could be mediated by the cell cycle arrest whereas in the resistant clone, the prolonged G(2) phase could play a key role to favour cell cycle progression and proliferation.
Asunto(s)
Antineoplásicos/toxicidad , Apoptosis , Ciclo Celular/efectos de los fármacos , Ciprofloxacina/toxicidad , Mitocondrias/efectos de los fármacos , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Resistencia a Antineoplásicos , Leucemia Mieloide/metabolismo , Leucemia Mieloide/patología , Ratones , Mitocondrias/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína X Asociada a bcl-2/metabolismoRESUMEN
Bone marrow stromal microenvironment is essential for the maintenance of the hematopoietic stem cell renewal both by cell-cell interaction and cytokine production. However, stromal cells also exhibit drug metabolizing activities and they may accumulate the drug and successively affect hematopoietic progenitors by a retarded release. Our study investigated the role of both primary culture of murine bone marrow stroma and established stromal cells (SR-4987) in modulating the "in vitro" toxic activity of Doxorubicin (DXR) against murine granulocyte-macrophage progenitors (CFU-GM). The main part of the study has been performed by a "in vitro" agar bilayer technique based on the CFU-GM assay performed over a feederlayer of stromal cells. The results suggest that bone marrow stromal cells play also an important role in decreasing the toxicity of Doxorubicin. Further SR-4987 stromal cells produce a Doxorubicin metabolite (not belonging to the series of metabolites described in literature) which is completely ineffective in inhibiting the growth of CFU-GM and the activity of topoisomerase I. Our data suggest that bone marrow stromal cells must be considered as a cell population having opposite pharmacological roles in modulating the drug toxicity on hematopoietic progenitors. In our model a mechanism of detoxification concerns the capacity of SR-4987 stromal cells to inactivate the drug. For a better prediction of drug hematotoxicity, it is very important to develop "in vitro" cell models able to discriminate between positive and negative modulation of drug toxicity that stromal cells can exert in the bone marrow microenvironment.
Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Comunicación Celular , Doxorrubicina/toxicidad , Células Madre Hematopoyéticas/efectos de los fármacos , Células Madre Hematopoyéticas/fisiología , Células del Estroma/efectos de los fármacos , Células del Estroma/fisiología , Animales , Línea Celular , Técnicas de Cocultivo , Células Madre Hematopoyéticas/patología , Ratones , Células del Estroma/patologíaRESUMEN
The effects of two substituted polychlorinated biphenyls, the 3,4,5,3',4,5' (PCB-169) and the 2,3,4,2',4',5' (PCB-138) forms, were examined on the expression of c-myc, c-jun, c-ras, and jun-b in 3T3-L1 cells. Northern blot analysis demonstrated that the two PCBs, which exhibit a coplanar and di-ortho-substituted configuration, activated these oncogenes differently. PCB-138 markedly induced overexpression of ras, jun, and myc, whereas PCB-169 led to the overexpression of jun-b. High-performance liquid chromatography analysis of the cell samples treated in medium without serum revealed a higher intracellular concentration of the 2,3,4,2',4',5'-hexachlorobiphenyl (hexaCB), whereas the 3,4,5,3',4'5'-hexaCB reached the same concentration in the sonicated samples of cells with or without serum. These results indicated that there was a relationship between PCB structure, bioavailability, and the capacity to stimulate oncogene expression.
Asunto(s)
Bifenilos Policlorados/toxicidad , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Proteínas ras/biosíntesis , Células 3T3 , Animales , Northern Blotting , División Celular/efectos de los fármacos , Sondas de ADN , Ratones , Bifenilos Policlorados/análisis , ARN/análisis , ARN/aislamiento & purificaciónRESUMEN
A workshop on alternative toxicological testing methodologies was convened by the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC) 26-31 January 1997 in Ispra, Italy, at the European Centre for the Validation of Alternative Methods. The purpose of the workshop was to assess the current status of alternative testing methodologies available to evaluate adverse human health and environmental effects of chemicals. Another objective of the workshop was to identify and recommend research needed to fill knowledge gaps that would lead to new test methodologies. Four work groups were established to address conceptual issues, acute toxicity, organ toxicity, and ecotoxicology. A joint workshop report was prepared for each topic and included recommendations for the development and use of alternative methods. Participants concluded that alternative methods and approaches are available that can be incorporated into tiered strategies for toxicological assessments. Use of these methods will reduce the numbers of animals required, and in some instances reduce animal pain and distress. It was recommended that future efforts to develop test methods should emphasize mechanism-based methods that can provide improved predictions of toxicity. Continued international cooperation was encouraged to facilitate future progress in the development of alternative toxicological testing methods. These methods will provide for improvements in human health protection, environmental protection, and animal welfare.
Asunto(s)
Alternativas a las Pruebas en Animales , Bienestar del Animal , Pruebas de Toxicidad/métodos , Animales , Contaminantes Ambientales , Humanos , Salud PúblicaRESUMEN
A new murine cell line, named MG1361, was established from mammary adenocarcinomas arising in a MMTV-neu transgenic mouse lineage where breast tumors develop in 100% of females, due to the overexpression of the activated rat neu oncogene in the mammary gland. The MG1361 cell line shows an epithelial-like morphology, has a poor plating efficiency, low clonogenic capacity, and a doubling time of 23.8 hours. Karyotype and flow cytometry analysis revealed a hypotetraploid number of chromosomes, whereas cell cycle analysis showed 31.2% of cells to be in the G1 phase, 21.4% in S and 47.4% in G2 + M. This cell line maintains a high level of neu expression in vitro. The MG1361 cell line was tumorigenic when inoculated in immunodeficient (nude) mice and the derived tumors showed the same histological features as the primary tumors from which they were isolated. MG1361 cells were positive for specific ER and PgR binding which was competed by tamoxifen, making this cell line useful for the evaluation of endocrine therapy. Moreover, they were sensitive to etoposide treatment, suggesting that they could be a model for the study of chemotherapy-induced apoptosis. As the tumors arising in MMTV-neu transgenic mice have many features in common with human mammary adenocarcinomas (Sacco et al., Gene Therapy 1995; 2: 493-497), this cell line can be utilized to perform basic studies on the role of the neu oncogene in the maintenance of the transformed phenotype, and to test novel protocols of therapeutic strategies.
Asunto(s)
Adenocarcinoma , Neoplasias de la Mama , Animales , Técnicas de Cultivo , Femenino , Citometría de Flujo , Cariotipificación , Ratones , Ratones Transgénicos , Receptor ErbB-2/genética , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Células Tumorales Cultivadas/ultraestructuraRESUMEN
Myelotoxicity of pesticides and algal toxins was detected in vitro by using the granulocyte-macrophage colony forming unit assay (CFU-GM), and the MTT test with SR-4987 cells, an established stromal cell line derived from a long term murine bone marrow culture, which may represent a suitable in vitro model for studying haematotoxicity. Comparison of the IC50s and NOELs obtained with the CFU-GM assay and those determined by testing the established stromal cells in the MTT cytotoxicity test indicate that inhibition of the proliferation of SR-4987 stromal cells is a sensitive in vitro endpoint for measuring myelotoxicity. It is suggested that this assay could be used as rapid and easy screening test for determining the haematotoxicity of environmental toxins. A comparison with results obtained with the MTT test on a non-differentiated cell line, 3T3-L1, was carried out to distinguish between non-specific interference with cell proliferation and specific toxicity on haemopoietic cells.
RESUMEN
To date only a few studies have been undertaken on DNA adducts formed by epoxybutene (EB) and diepoxybutane (DEB), the two active metabolites of 1,3-butadiene. Our interests have focused on further investigating DNA alkylation by the two epoxides, especially in relation to the development of a method for human biomonitoring. Here, following the reaction of deoxyadenosine monophosphate and poly(dA-dT)(dA-dT) with DEB and subsequent HPLC, we have identified an adenine adduct. MS analyses indicate the structure of an adenine adducted by DEB at the N6 position. A HPLC/32P-postlabelling method was developed for its measurement in DNA samples and the adduct was detected in calf thymus DNA and DNA from Chinese hamster ovary cells exposed to DEB. The 100% labelling efficiency during postlabelling, the amount of the adduct and its elution before the normal nucleotides during HPLC suggest it could be a suitable indicator of BUT exposure.
Asunto(s)
Adenina/análisis , Adenina/metabolismo , Butadienos/metabolismo , Butadienos/toxicidad , Aductos de ADN/análisis , Aductos de ADN/metabolismo , Daño del ADN , ADN/análisis , Contaminantes Ambientales/metabolismo , Contaminantes Ambientales/toxicidad , Compuestos Epoxi/análisis , Compuestos Epoxi/metabolismo , Adamantano/análogos & derivados , Adamantano/metabolismo , Animales , Células CHO , Bovinos , Cromatografía Líquida de Alta Presión , Cricetinae , ADN/efectos de los fármacos , ADN/metabolismo , Aductos de ADN/aislamiento & purificación , Compuestos Epoxi/toxicidad , Marcaje Isotópico/métodos , Radioisótopos de Fósforo , Poli dA-dT/metabolismo , Espectrometría de Masa Bombardeada por Átomos VelocesRESUMEN
The European Centre for the Validation of Alternative Methods (ECVAM) has recently been established. The Centre will co-ordinate at Community level the validation of alternative test methods, maintain a database and act as a focal point for the exchange of information on alternative procedure, and carry out research and training. ECVAM aims to promote dialogue between legislators, industries, biomedical scientists, consumer organisations and animal welfare groups with a view to the development, validation and international recognition of alternative test methods.
RESUMEN
1,2-Epoxy-3-butene and 1,2:3,4-diepoxybutane, the two oxidative metabolites of 1,3-butadiene, are considered to be involved in some of the carcinogenicity of the parent compound. Diepoxybutane is a bifunctional alkylating agent and reacts with DNA to form monoadducts and cross-links. We investigated DNA alkylation after exposure to diepoxybutane in order to develop a method for human biomonitoring. After reacting dAMP and then poly(dA-dT) (dA-dT) with diepoxybutane, we identified a major adenine adduct. Preliminary mass spectrometry indicated an adenine adducted by diepoxybutane at the N6 position. A high-performance liquid chromatography/32P-postlabelling method was developed, and the adduct was detected in calf thymus DNA and in DNA from Chinese hamster cells after exposure to diepoxybutane. The labelling efficiency, the amount of the adduct and its stability suggest that it could be a suitable indicator of exposure to butadiene.
Asunto(s)
Adenina/metabolismo , Butadienos/análisis , Exposición a Riesgos Ambientales , Compuestos Epoxi/metabolismo , Mutágenos/análisis , Adenosina Monofosfato/metabolismo , Alquilación , Animales , Células Cultivadas , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada , Cricetinae , Cricetulus , ADN/metabolismo , Desoxiadenosinas/metabolismo , Femenino , OvarioRESUMEN
We have developed an HPLC-32P-postlabelling procedure to detect DNA adducts formed by epoxybutene and diepoxybutane. The method exploits the interaction of the two epoxides with deoxynucleotides and polydeoxynucleotides to optimize the HPLC enrichment of adducted nucleotides before 32P-postlabelling. Using this approach, a number of guanine adducts were identified after the exposure of dGMP, poly(dG-dC) or calf thymus DNA to epoxybutene and diepoxybutane, and a major adenine adduct was identified in poly(dA-dT) and calf thymus DNA exposed to diepoxybutane.
Asunto(s)
Daño del ADN , ADN/análisis , Compuestos Epoxi/toxicidad , Animales , Bovinos , Cromatografía Líquida de Alta Presión , ADN/efectos de los fármacos , Monitoreo del Ambiente/métodos , Estudios de Evaluación como Asunto , Humanos , Técnicas In Vitro , Mutágenos/toxicidad , Radioisótopos de FósforoAsunto(s)
Pruebas de Mutagenicidad/métodos , Bleomicina/toxicidad , Aberraciones Cromosómicas , Cisplatino/toxicidad , Estudios de Evaluación como Asunto , Humanos , Cooperación Internacional , Melfalán/toxicidad , Pruebas de Micronúcleos , Pruebas de Mutagenicidad/normas , Mutágenos/toxicidad , Control de Calidad , Intercambio de Cromátides HermanasAsunto(s)
Monitoreo del Ambiente/métodos , Mutágenos/administración & dosificación , Células Sanguíneas/efectos de los fármacos , ADN/efectos de los fármacos , Exposición a Riesgos Ambientales , Hemoglobinas/genética , Humanos , Hipoxantina Fosforribosiltransferasa/genética , Mutación , Proteínas/efectos de los fármacosRESUMEN
Inhibition of the methylation of arsenic in rabbits by ip injection of periodate-oxidized adenosine (PAD) prior to an iv injection of 74As-arsenate (AsV; 0.4 mg As/kg body wt) caused a marked increase in the retention of 74As in both the cellular organelles and the soluble fractions of liver and kidney. One day after exposure, almost 30% of the arsenic in the liver and about 40% of the arsenic in the kidney was recovered in the nuclear fraction. In the liver nuclei, the inhibition of the methylation increased the 74As content of the insoluble fraction and most of this arsenic was protein-bound. The major part of the soluble intranuclear 74As was in the form of AsIII, formed by reduction of the administered AsV. In the liver, PAD also caused a pronounced increase in the 74As content of the microsomal fraction. In the kidneys, where most of the arsenic was present as AsV, there was a marked accumulation of arsenic in the mitochondria.
Asunto(s)
Arseniatos/farmacología , Arsénico/farmacocinética , Fracciones Subcelulares/metabolismo , Animales , Arsénico/metabolismo , Fenómenos Químicos , Química , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/ultraestructura , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/ultraestructura , Metilación , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Conejos , Fracciones Subcelulares/efectos de los fármacosRESUMEN
The effects of 6 weeks feeding with diets low in methionine, choline, or proteins on the biotransformation and retention of 76As-labelled arsenite (0.4 mg As/kg bw) in rabbits have been studied. All test diets caused a significant decrease in the urinary excretion of dimethyl[76As]-arsinic acid, the main metabolite of inorganic arsenic. This gave rise to an increased retention of arsenic in the tissues, especially liver and lung. The test diets also caused a specific increase of the arsenic concentration in liver microsomes. The results indicate that subjects with a poor nutritional status have a lower capacity of methylating and thereby detoxifying inorganic arsenic.
Asunto(s)
Arsénico/metabolismo , Arsenitos , Colina/administración & dosificación , Dieta , Proteínas en la Dieta/administración & dosificación , Metionina/administración & dosificación , Animales , Biotransformación , Masculino , Metilación , Conejos , Distribución TisularRESUMEN
The metabolism of dimethylarsinic acid (DMA) a common pesticide and the main metabolite of inorganic arsenic in mammals, has been studied in mice, hamsters and man. Mice and hamsters were administered a single dose of 74As-DMA (40 mg As/kg body weight) orally, while a human subject ingested DMA corresponding to 0.1 mg As/kg body weight. Ion exchange chromatography, paper electrophoresis, thin layer chromatography as well as arsine generation--gas chromatography combined with atomic absorption spectrophotometry or mass spectrometry were used to characterize the arsenic metabolites in urine and feces collected over 48 hours after treatment. In mice and hamsters 3.5% and 6.4% of the dose, respectively, were excreted in urine in the form of trimethylarsine oxide (TMAO). No TMAO was found in feces. A DMA-complex was detected in urine and feces. It amounted to about 13% of the dose in mice and 15% in hamsters. About 80-85% of the dose was eliminated in urine and feces in the form of unmetabolized DMA. No demethylation of DMA to inorganic arsenic was observed. In man, about 4% of the dose was excreted in urine as TMAO and about 80% as DMA.
Asunto(s)
Arsenicales/metabolismo , Ácido Cacodílico/metabolismo , Herbicidas/metabolismo , Adulto , Animales , Biotransformación , Ácido Cacodílico/orina , Cromatografía en Capa Delgada , Cricetinae , Electroforesis en Papel , Heces/análisis , Humanos , Cinética , Masculino , Metilación , Ratones , Especificidad de la EspecieRESUMEN
The ability of rabbit alveolar macrophages to dissolve two arsenic compounds, 74As-labeled lead arsenate and arsenic trisulfide, was studied in vitro. The solubilities in water of these two compounds are related differently to pH. The solubility of lead arsenate increases and that of arsenic trisulfide decreases with decreasing pH. The radiolabeled particles were incubated with and without macrophages for up to 3 days, whereafter the amount of 74As in soluble form and the amount in particle form and/or bound to macrophages were determined. The results strongly support the hypothesis that the dissolution of particles by macrophages is influenced by the acid milieu in the phagosomes. About 14% of the 74As-labeled lead arsenate particles incubated for 3 days with the macrophages was released into the culture medium, compared with about 2% of the particles incubated with the culture medium without macrophages. With the arsenic trisulfide particles, less soluble 74As was released into the medium in samples with macrophages than in samples without macrophages, although the solubility in all incubations was considerably greater than that for lead arsenate. The results indicate that dissolution in the phagosomes of the macrophages may be of great importance for the clearance of particles such as lead arsenate, which are more soluble at pH 4 than at pH 7.
Asunto(s)
Arseniatos/metabolismo , Arsénico/metabolismo , Arsenicales , Plomo/metabolismo , Macrófagos/metabolismo , Alveolos Pulmonares/metabolismo , Sulfuros/metabolismo , Animales , Cromatografía por Intercambio Iónico , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Conejos , SolubilidadRESUMEN
The absorption, biotransformation, and tissue retention of arsenic following intratracheal and oral administration of 74As-labeled sodium arsenite, sodium arsenate, arsenic trisulfide (suspension), and lead arsenate (suspension) have been studied in hamsters, and correlated to the in vitro and in vivo solubility of the compounds. After intratracheal instillation, the clearance of 74As from the lungs was positively correlated to the in vivo solubility. Less than 0.1% of the sodium arsenite and sodium arsenate was retained in the lungs after 3 days, compared to 1.3% of the arsenic trisulfide particles and 45% of the lead arsenate particles. The latter showed a very low solubility both in vivo and in vitro. In general, orally administered arsenic had a shorter biological half-life than intratracheally administered, especially when given in the form of arsenic trisulfide or lead arsenate particles, which seemed to be absorbed to only 20-30% in the gastrointestinal tract. Reduction, oxidation, and methylation of arsenic varied to a great extent with the arsenic compound and the route of exposure. Trivalent arsenic was methylated to a greater extent than pentavalent and less soluble compounds (suspended particles) more than dissolved compounds. The trivalent arsenic compounds caused higher concentrations than the pentavalent in the upper gastrointestinal tract but not in other tissues.
Asunto(s)
Arseniatos/metabolismo , Arsénico/metabolismo , Arsenitos , Administración Oral , Animales , Arseniatos/orina , Arsénico/orina , Cricetinae , Instilación de Medicamentos , Masculino , Mesocricetus , Solubilidad , TráqueaAsunto(s)
Arsénico/metabolismo , Arsenicales/biosíntesis , Ácido Cacodílico/biosíntesis , Deficiencia de Colina/metabolismo , Animales , Inactivación Metabólica/efectos de los fármacos , Masculino , Tasa de Depuración Metabólica/efectos de los fármacos , Metilación , Conejos , S-Adenosilmetionina/antagonistas & inhibidores , Distribución TisularRESUMEN
The biotransformation, tissue retention, intracellular binding and biokinetics of arsenic were studied in rabbits exposed to [74As]arsenate (0.4 mg As/kg body wt., i.v.). Inhibition of the methyltransferase activity by injection of periodate-oxidized adenosine (PAD) caused a marked decrease of the formation of [74As]dimethylarsinic acid (DMA), which gave rise to 1.5-4 times increased tissue levels of 74As. This is almost the same as reported for rabbits given arsenite in combination with PAD and was due to a rapid reduction of the arsenate to arsenite which bound to the tissues. Only about 30% of the arsenate given was excreted unchanged in the urine, indicating that a large part was reduced to AsIII. Thus the methylation to DMA seems to be almost as important for the detoxication following exposure to arsenate as that following exposure to arsenite. In the rabbits with normal methylating capacity 50-70% of the produced AsIII was methylated to DMA. The liver was the only organ in which DMA was present 1 h after the administration, indicating that this is the main site of the methylation. The DMA was rapidly cleared from all tissues except the thyroid.